Compare Tenet Healthcare Corporation (THC) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Exxon Mobil Corporation — how do they compare? Tenet Healthcare Corporation trades at $260 (market cap $20.92B), while Exxon Mobil Corporation trades at $167 (market cap $674.56B). The key difference: Exxon Mobil Corporation is far larger — about 32.2× Tenet Healthcare Corporation's market cap, and Exxon Mobil Corporation pays a 2.51% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Exxon Mobil Corporation for 99 Days on average.
| THC | XOM | |
|---|---|---|
Market Cap | $20.92B | $674.56B |
Volume | 455,764 | 9,350,473 |
Sector | Health | Energy |
52-Week High | $280.77 | $171.52 |
52-Week Low | $161.37 | $110.64 |
Typical Hold Time | 15 Days | 99 Days |
Enterprise Value | $32.00B | $706.34B |
Dividend Yield | — | 2.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
ExxonMobil (XOM) trades at $168.56, up 2.48% with strong technical momentum and bullish moving average signals. The company maintains solid profitability with 9.07% net margin and 12.55% ROE, though revenue declined to $323.91B in 2025. Recent news highlights potential Venezuela investment and Guyana/Permian expansion, while analyst consensus shows 36% buy ratings with $168.08 price target.
XOM presents a balanced opportunity with operational strength and strategic growth initiatives, though faces headwinds from declining revenue trends and geopolitical risks. The stock's current valuation at 21.11 P/E appears reasonable given cash flow generation, but investors should monitor execution on production targets and oil price volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
